Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
Sleep disruption is a common complaint in levodopa-treated parkinsonian patients. A survey of 100 parkinsonian patients revealed prominent sleep complaints in 74%. Sleep complaints were unrelated to patient age and the duration of disease but increased in prevalence with longer periods of levodopa therapy. Sleep abnormalities tended to increase in severity with continued treatment and insomnia tended to be followed by daytime somnolence, altered dream events, and episodic nocturnal vocalization and myoclonus. While dyskinetic side effects and on-off syndrome were encountered in patients with and without sleep complaints, 98% of patients experiencing psychiatric side effects also reported sleep disruption. It is suggested that sleep-related symptoms constitute an early stage of levodopa-induced dopaminergic psychiatric toxicity in the parkinsonian population. Clinical and experimental observations suggest that serotonergic mechanisms are important in this symptom complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
A community‐based study of sleep disorders in patients with Parkinson's disease
Tandberg, E., Larsen, J. P., & Karlsen, K. (1998) · Movement Disorders · doi:10.1002/mds.870130606 · Cited by 450
Hallucinations, REM sleep, and Parkinson’s disease: A medical hypothesis
Arnulf, I., Bonnet, A.-M., Damier, P., Bejjani, B.-P., Seilhean, D., Derenne, J.-P., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.2.281 · Cited by 442
Comorbidity of the nonmotor symptoms of Parkinson's disease
Shulman, L. M., Taback, R. L., Bean, J., & Weiner, W. J. (2001) · Movement Disorders · doi:10.1002/mds.1099 · Cited by 417
Self-citationVisual Hallucinations Associated With Parkinson Disease
Sanchez-Ramos, J. R., Ortoll, R., & Paulson, G. W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550120077019 · Cited by 324
Metadata
- Authors
- Nausieda, P. A., Weiner, W. J., Kaplan, L. R., Weber, S., & Klawans, H. L.
- Affiliations
- Rush University Medical Center (US)
- ORCID
- Nausieda, Paul A.
- Venue
- Clinical Neuropharmacology
- Published
- 1982
- Volume
- 5
- Issue
- 2
- Pages
- 183-194
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2060147156
- Cited by
- 245
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 5 · 2014: 4 · 2013: 9 · 2012: 8
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
- Keywords
- sleep disruption, levodopa, Parkinson's disease, insomnia, daytime somnolence, dream content, nocturnal vocalization, myoclonus, dyskinesia, on-off phenomenon, serotonergic mechanisms
- MeSH terms
- Aged, Bromocriptine, Carbidopa, Dreams, Drug Therapy, Combination, Female, Humans, Sleep Initiation and Maintenance Disorders, Levodopa, Male, Middle Aged, Parkinson Disease, Psychoses, Substance-Induced, Sleep Stages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis. https://app.cochat.ai/papers/10.1097/00002826-198205020-00003
- The paper
- Nausieda, P. A., Weiner, W. J., Kaplan, L. R., Weber, S., & Klawans, H. L. (1982). Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-198205020-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.